Coverage dated October 20, 2026

GLP-1 recall: Mounjaro, Zepbound ingredient risk raised to second-highest level

Headline from MLive

A popular GLP-1 ingredient is being recalled nationwide over sterility concerns. Here's how to tell if your medication is impacted.

MLive's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

6 articles, oldest first.

Quartz
A GLP-1 drug that shares an ingredient with Zepbound and Mounjaro is being recalled (opens Quartz)
Published Oct 20, 2026
Quartz's feed description
The company received an FDA warning letter in December 2025 citing deficiencies in how it makes sterile drug products
MLive
GLP-1 recall: Mounjaro, Zepbound ingredient risk raised to second-highest level (opens MLive)
Published Oct 20, 2026
MLive's feed description
A popular GLP-1 ingredient is being recalled nationwide over sterility concerns. Here's how to tell if your medication is impacted.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Separate coverage close to this update in time and subject.